Obagi Medical Products, Inc. (NASDAQ:OMPI)

CAPS Rating: 4 out of 5

A pharmaceutical company focused on the aesthetic and skin health markets. The Company develops and commercializes prescription-based, topical skin health systems.

Recs

1
Player Avatar Alaskatrader42 (< 20) Submitted: 4/28/2008 9:00:19 PM : Outperform Start Price: $7.76 OMPI Score: +65.46

just a really god buy

Featured Broker Partners


Advertisement